Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin

Affiliation auteurs!!!! Error affiliation !!!!
TitreNuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin
Type de publicationJournal Article
Year of Publication2018
AuteursTammam SN, Azzazy HME, Lamprecht A
JournalEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume129
Pagination74-79
Date PublishedAUG
Type of ArticleArticle
ISSN0939-6411
Mots-clésChitosan nanoparticles, Glioma, Lactoferrin, Nuclear delivery, Nuclear localization sequence, Nuclear targeting
Résumé

Lactoferrin (Lf) exerts anti-cancer effects on glioma, however, the exact mechanism remains unclear. Despite possessing a nuclear localization sequence (NLS), Lf was found to allocate only in the cytoplasm of glioma 261. Lf was therefore loaded into nuclear and cytoplasmic targeted nanoparticles (NPs) to determine whether nuclear delivery of Lf would enhance its anti-cancer effect. Upon treatment with 300 and 800 mu g/mL Lf loaded chitosan NPs, nuclear targeted Lf-NPs showed 1.3 and 2.7 folds increase in cell viability, whereas cytoplasmic targeted Lf-NPs at 300 mu g/mL decreased cell viability by 0.8 folds in comparison to free Lf and controls. Results suggest that the cytotoxicity of Lf on glioma is attributable to its cytoplasmic allocation. Nuclear delivery of Lf induced cell proliferation rather than cytotoxicity, indicating that the mode of action of Lf in glioma is cell location dependent. This calls for caution about the general use of Lf as an anti-cancer protein.

DOI10.1016/j.ejpb.2018.05.027